Lexicon Pharmaceuticals

-$0.08 (-4.12%) As of 11:15 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LXRX and other ETFs, options, and stocks.

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes.

CEO
Lonnel Coats
Employees
87
Headquarters
The Woodlands, Texas
Founded
1995

LXRX Key Statistics

Market cap
290.21M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.68M
High today
$2.05
Low today
$1.78
Open price
$1.92
Volume
1.14M
52 Week high
$6.33
52 Week low
$1.31

LXRX Earnings

-$0.28
-$0.19
-$0.09
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure